Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
暂无分享,去创建一个
Donald M Bers | Adam J Engler | Jaecheol Lee | Yang K Xiang | Haodi Wu | D. Bers | A. Engler | Joseph C. Wu | J. Gold | L. Vincent | Y. Xiang | Joseph C Wu | K. Sallam | Haodi Wu | Jared M Churko | Elena Matsa | Joseph D Gold | Ludovic G Vincent | E. Matsa | Arun Sharma | Arun Sharma | F. Lan | Feng Lan | Mingxia Gu | Joseph D. Gold | Mingxia Gu | Jared M. Churko | Qingtong Wang | Karim I Sallam | Qingtong Wang | Jaecheol Lee | Elena Matsa | Karim Sallam
[1] M. Cho,et al. Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression* , 1999, The Journal of Biological Chemistry.
[2] M. Böhm,et al. Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. , 1996, Journal of the American College of Cardiology.
[3] T. Ichisaka,et al. Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .
[4] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Martin Dugas,et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2012, Nature Medicine.
[6] F. Dilworth,et al. Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A , 2012, Proceedings of the National Academy of Sciences.
[7] Y. Xiang. Compartmentalization of &bgr;-Adrenergic Signals in Cardiomyocytes , 2011, Circulation research.
[8] Y. Jeon,et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development , 2005, Cellular and Molecular Life Sciences CMLS.
[9] Charles E. Murry,et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.
[10] P. Karczewski,et al. Activation of (cid:98) 2 -Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure , 1998 .
[11] E. McNally,et al. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.
[12] R. Hershberger,et al. Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[13] S. Steffens,et al. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[14] Ulrike Mende,et al. Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.
[15] Donald M Bers,et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.
[16] O. Brodde. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.
[17] Suresh Poosala,et al. Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction , 2008, Journal of Pharmacology and Experimental Therapeutics.
[18] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[19] P A Insel,et al. Beta-adrenergic receptors and receptor signaling in heart failure. , 1999, Annual review of pharmacology and toxicology.
[20] Sean Thomas,et al. A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development , 2012, Cell.
[21] Samira M. Azarin,et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.
[22] S. Jamieson,et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.
[23] R. Stewart,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[24] Mark A Sussman,et al. &bgr;-Adrenergic Regulation of Cardiac Progenitor Cell Death Versus Survival and Proliferation , 2013, Circulation research.
[25] B. Kobilka,et al. Myocyte Adrenoceptor Signaling Pathways , 2003, Science.
[26] George A. Truskey,et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.
[27] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[28] Samuel Bernard,et al. Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.
[29] Euan A. Ashley,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[30] Yuan-Ping Pang,et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.
[31] E. Lakatta,et al. Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. , 1994, The Journal of biological chemistry.
[32] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[33] G. Baillie. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases , 2009, The FEBS journal.
[34] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[35] Martin J. Lohse,et al. What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.
[36] C. Vettel,et al. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. , 2013, Journal of the American College of Cardiology.
[37] Lior Gepstein,et al. Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.
[38] Benjamin Meder,et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy , 2013, EMBO molecular medicine.
[39] J. Pepper,et al. Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. , 1993, Circulation.
[40] Robert J. Lefkowitz,et al. Seven-transmembrane-spanning receptors and heart function , 2002, Nature.
[41] Jonathan Seidman,et al. Genetic causes of human heart failure. , 2005, The Journal of clinical investigation.
[42] Gordon Keller,et al. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.
[43] R. Quaife,et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. , 2002, The New England journal of medicine.
[44] Hammond Hk,et al. Beta-adrenergic receptors and receptor signaling in heart failure. , 1999 .
[45] Masahiko Hoshijima,et al. The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy , 2002, Cell.
[46] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.